Details for New Drug Application (NDA): 084030
✉ Email this page to a colleague
NDA 084030 describes AMOSENE, which is a drug marketed by Ferndale Labs and is included in one NDA. Additional details are available on the AMOSENE profile page.
The generic ingredient in AMOSENE is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
The generic ingredient in AMOSENE is meprobamate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
Summary for 084030
| Tradename: | AMOSENE |
| Applicant: | Ferndale Labs |
| Ingredient: | meprobamate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084030
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
